Eckert & Ziegler Strahlen- Und Medizintechnik AG (EUZ) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Headlines Articles Press releases Eckert & Ziegler Strahlen- Und Medizintechnik AG

Home
Companies
Eckert & Ziegler Strahlen- Und Medizintechnik AG

BRIEF

published on 11/14/2024 at 07:50, 7 days 3 hours ago

Eckert & Ziegler Reports Strong Growth in First Nine Months of 2024

Eckert & Ziegler 2024 Forecast Financial Growth Medical Segment Isotope Products
PRESS RELEASE

published on 11/14/2024 at 07:45, 7 days 3 hours ago

Eckert & Ziegler Continues on Growth Path with Strong 9-Month Results in 2024
Eckert & Ziegler SE reports strong 9-month results with 17% sales growth reaching €215.5 million. Forecasting €55 million EBIT for 2024. Explore more at: https://www.ezag.com/q32024en/

Sales Growth EBIT 2024 Forecast Eckert & Ziegler SE 9-Month Results
BRIEF

published on 11/13/2024 at 08:59, 8 days 1 hour ago

Eckert & Ziegler Forge Alliance with Telix Pharmaceuticals for Actinium-225

Clinical Trials Eckert & Ziegler Telix Pharmaceuticals Radiopharmaceuticals Actinium-225
PRESS RELEASE

published on 11/13/2024 at 08:54, 8 days 1 hour ago

EQS-Adhoc: Eckert & Ziegler and Telix Pharmaceuticals Enter into a Collaboration and Licence Agreement for Actinium-225
Eckert & Ziegler SE signs collaboration and license agreement with Telix Pharmaceuticals for Ac-225 production, aiming to become a major supplier in the radiopharmaceutical industry

Collaboration Telix Pharmaceuticals Eckert & Ziegler SE License Agreement Ac-225
BRIEF

published on 10/15/2024 at 16:38, 1 month 5 days ago

Eckert & Ziegler Reports Growth in Sales and Earnings for First Nine Months of 2024

Net Income Eckert & Ziegler Financial Forecast EBIT Growth 2024 Sales
PRESS RELEASE

published on 10/15/2024 at 16:33, 1 month 5 days ago

EQS-Adhoc: Eckert & Ziegler Again Increases Sales and Earnings in the First Nine Months Compared to Previous Year
Eckert & Ziegler SE reports increased sales and earnings in the first nine months of 2024 compared to previous year. Strong performance indicated by sales of EUR 215.5 million and EBIT of EUR 46.7 million

Financial Results Sales Increase Earnings Growth 2024 Forecast Eckert & Ziegler SE
BRIEF

published on 10/08/2024 at 08:05, 1 month 13 days ago

Eckert & Ziegler and GlyTherix Sign Lutetium-177 Supply Agreement

Clinical Trials Cancer Treatment Radiopharmaceuticals Lutetium-177 GlyTherix Partnership
PRESS RELEASE

published on 10/08/2024 at 08:00, 1 month 13 days ago

Eckert & Ziegler and GlyTherix Sign Agreement for Lutetium-177 Supply
Eckert & Ziegler and GlyTherix sign global agreement for Lutetium-177 supply, aiming for innovative cancer treatments with targeted radiotherapy

Clinical Trials Eckert & Ziegler Lutetium-177 GlyTherix Radiotherapy
BRIEF

published on 10/02/2024 at 11:48, 1 month 18 days ago

Eckert & Ziegler: Spin-off of Pentixapharm AG Registered

Frankfurt Stock Exchange Spin-off Commercial Register Pentixapharm AG Share Allocation
PRESS RELEASE

published on 10/02/2024 at 11:43, 1 month 18 days ago

Eckert & Ziegler: Spin-off of Pentixapharm AG Registered with the Commercial Register
Eckert & Ziegler SE successfully completes the spin-off of Pentixapharm AG, transferring shares to Pentixapharm Holding AG as per the approved resolution at the Annual General Meeting

Shareholders Spin-off Commercial Register Eckert & Ziegler SE Pentixapharm AG

1 2 ... 8

Accesswire

Published on 11/21/2024 at 10:03, 48 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 51 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 51 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 16 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 26 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 21 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 46 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 49 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 51 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 51 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 53 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 31 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 6 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 6 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE